A research study to evaluate the effectiveness of panchanimbakam churna tablet and pathyadi lepa(Ayurvedic ointment) in psoriasis disease

Not yet recruiting

• Conditions: Medical and Surgical. Ayurveda Condition: KITIBAH, (2) ICD-10 Condition: L409||Psoriasis, unspecified. Ayurveda Condition: KITIBAH,

• Registration Number: CTRI/2021/02/031318
• Lead Sponsor: SDM College of Ayurveda Hassan

Brief Summary

This study is an open label single arm prospective clinical study to assess the effectiveness of panchanimbakam churna vati and pathyadi lepa in management of kitibha kushta within age group of 18 to 60 for 30 days in 30 patients. The study will be conducted in  one center in India. Secondary outcomes will be assessed by Pasi scale after 30 days

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-02-15
• Study Start: 2021-02-22

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients suffering with Kitibha Kushta <5years of chronicity.
• Patients of either gender, aged between 18-60 years.
• Patient willing to participate in the study and ready to sign informed consent form.

Exclusion Criteria

• Patients with systemic illness such as impaired cardiac, renal and hepatic functions.
• Metabolic disorders namely diabetes mellitus type 2 and essential hypertension.
• Pregnant women and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in the PASI scale and symptoms of Kitibha Kushta	outcomes will be assessed at baseline, 15 days and 30 days

Secondary Outcome Measures

Name	Time	Method
PASI scale	15 days and 30 days

Trial Locations

Locations (1)

SDM College of Ayurveda and Hospital, Hassan; 🇮🇳 Hassan, KARNATAKA, India

SDM College of Ayurveda and Hospital, Hassan

🇮🇳Hassan, KARNATAKA, India

Dr Kalpana

Principal investigator

9686814628

pg19130@sdmcahhassan.org